News-Jiangxi Institute | Jiangxi Biology

股票代码：******

OA Login

Language

Group News

Industry News

Policies and Regulations

Oct 06,2014

International medical personnel remind disaster area residents to beware of tetanus

Xinhua Net Jakarta, January 15 (Reporters Wu Qiang, Yu Qianliang) The international medical relief organization "Doctors Without Borders" reminded residents in the Aceh disaster area of Indonesia on the 15th to be cautious of tetanus infection when clearing debris. Currently, the Aceh disaster area is hot and rainy, and many decomposing corpses are still buried in the rubble. People searching for useful items in the ruins of destroyed houses are easily infected with tetanus bacteria. Officials from "Doctors Without Borders" said the organization has found 67 cases of tetanus in the city of Banda Aceh, and it is estimated that the number of tetanus infections will significantly increase in the coming days. These officials warned that even with immediate treatment, infection

See more+

Oct 06,2014

Industry experts support: What is the direction of drug research and development for Chinese enterprises?

China is a major global producer of raw pharmaceutical materials and an even larger consumer of medicines. However, the chemical drugs produced domestically currently lack independent intellectual property rights, with 97% being generic drugs, placing China at a disadvantage in international competition. In response, relevant experts have proposed suggestions for the future R&D direction and product structure adjustment of Chinese pharmaceutical companies. Adjusting the product structure to implement more "three-dimensional cross" approaches. Nowadays, people increasingly value health and improving quality of life. Coupled with the accelerated construction of the public health system, the improvement of disease prevention and control systems, the strengthening of rural medical and health infrastructure, and the establishment of new cooperative medical systems, this has created favorable conditions for the pharmaceutical economy.

See more+

Oct 06,2014

Hypertension vaccine expected to be available within five years

In the near future, some hypertension patients may be able to effectively control their blood pressure simply by receiving a vaccine injection. This therapeutic vaccine is the result of years of research by a Swiss pharmaceutical company. Currently, the vaccine is still in small-scale clinical trials, with 48 hypertension patients having completed one injection course. The expected blood pressure-lowering effect can last for about 4 months. It is reported that the vaccine will be marketed within five years, and the related research results have been published in the renowned British medical journal The Lancet. The hypertension vaccine mainly targets the renin-angiotensin system; once injected into the body, the vaccine "infects" the patient and stimulates the immune system

See more+

Oct 06,2014

Zhejiang established the nation's first non-profit joint drug procurement center

On August 18, more than 50 pharmacy owners from 11 cities in Zhejiang Province gathered in Hangzhou to officially establish the "Zhejiang Province Pharmaceutical Retail (Chain) Enterprise Joint Procurement Center." They decided to collectively conduct drug bidding with pharmaceutical manufacturers to reduce costs and seek new development opportunities. This is the first non-profit joint drug procurement center in Zhejiang Province and even nationwide. Industry insiders say this marks a shift in the pharmacy industry from passive price reductions to "active initiatives." The development of pharmacies has reached a freezing point. One of the initiators of this joint procurement center, Lin Zhenhua, General Manager of Hangzhou Buyi Pharmacy, told reporters that since 2002

See more+

< 1...22 23 24 25 >

Add:

Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China

Board Office:

Domestic Sales:

International Sales: